EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access

Targeting mitochondrial Ca 2+ uptake for the treatment of amyotrophic lateral sclerosis

Renjia Zhong, Michael T Rua, Lan Wei-LaPierre iD

The Journal of Physiology · 2024

DOI: 10.1113/jp284143 ↗

At a glance

Übersichtsarbeit in The Journal of Physiology, 2024. Written by Renjia Zhong and 2 co-authors. Institution: Department of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, FL, USA. Major MEDLINE topics: Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases. Cited 11 times so far (Crossref); 311 references. The full text is freely available in PubMed Central. Funded by: NINDS NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Amyotrophic lateral sclerosis (ALS) is a rare adult‐onset neurodegenerative disease characterized by progressive motor neuron (MN) loss, muscle denervation and paralysis. Over the past several decades, researchers have made tremendous efforts to understand the pathogenic mechanisms underpinning ALS, with much yet to be resolved. ALS is described as a non‐cell autonomous condition with pathology detected in both MNs and non‐neuronal cells, such as glial cells and skeletal muscle. Studies in ALS patient and animal models reveal ubiquitous abnormalities in mitochondrial structure and function, and disturbance of intracellular calcium homeostasis in various tissue types, suggesting a pivotal role of aberrant mitochondrial calcium uptake and dysfunctional calcium signalling cascades in ALS pathogenesis. Calcium signalling and mitochondrial dysfunction are intricately related to the manifestation of cell death contributing to MN loss and skeletal muscle dysfunction. In this review, we discuss the potential contribution of intracellular calcium signalling, particularly mitochondrial calcium uptake, in ALS pathogenesis. Functional consequences of excessive mitochondrial calcium uptake and possible therapeutic strategies targeting mitochondrial calcium uptake or the mitochondrial calcium uniporter, the main channel mediating mitochondrial calcium influx, are also discussed. image

Subjects

MeSH terms (MEDLINE)

Amyotrophic Lateral SclerosisNeurodegenerative DiseasesAnimalsHumansCalciumMotor NeuronsMitochondria

Author keywords

ALSmitochondria calciummotor neuronskeletal muscletherapeutic target

Substances

Calcium

Authors and institutions

  • Department of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, FL, USA.
  • Department of Emergency Medicine, the First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Myology Institute, University of Florida, Gainesville, FL, USA.

ORCID profiles: Lan Wei-LaPierre

Funding

  • NINDS NIH HHS

Cite

APA

Zhong, R., Rua, M. T., & Wei-LaPierre, L. (2024). Targeting mitochondrial Ca 2+ uptake for the treatment of amyotrophic lateral sclerosis. The Journal of Physiology. https://doi.org/10.1113/jp284143

Vancouver

Zhong R, Rua MT, Wei-LaPierre L. Targeting mitochondrial Ca 2+ uptake for the treatment of amyotrophic lateral sclerosis. The Journal of Physiology. 2024. doi:10.1113/jp284143

BibTeX
@article{Zhong2024,
  author = {Zhong, Renjia and Rua, Michael T and Wei-LaPierre, Lan},
  title = {Targeting mitochondrial Ca 2+ uptake for the treatment of amyotrophic lateral sclerosis},
  journal = {The Journal of Physiology},
  year = {2024},
  doi = {10.1113/jp284143}
}
Start for free →